SG11202008078QA - Treatment and prevention of pre-eclampsia - Google Patents

Treatment and prevention of pre-eclampsia

Info

Publication number
SG11202008078QA
SG11202008078QA SG11202008078QA SG11202008078QA SG11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA
Authority
SG
Singapore
Prior art keywords
eclampsia
prevention
treatment
Prior art date
Application number
SG11202008078QA
Other languages
English (en)
Inventor
Vries Sijmen De
Bruno Giannetti
Original Assignee
Pharming Intellectual Property B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property B V filed Critical Pharming Intellectual Property B V
Publication of SG11202008078QA publication Critical patent/SG11202008078QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202008078QA 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia SG11202008078QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18159064 2018-02-28
PCT/EP2019/055001 WO2019166556A1 (fr) 2018-02-28 2019-02-28 Traitement et prévention de pré-éclampsie

Publications (1)

Publication Number Publication Date
SG11202008078QA true SG11202008078QA (en) 2020-09-29

Family

ID=61521416

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008078QA SG11202008078QA (en) 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia

Country Status (15)

Country Link
US (1) US20200390872A1 (fr)
EP (1) EP3758739B1 (fr)
JP (1) JP2021515757A (fr)
KR (1) KR20210005549A (fr)
CN (1) CN111818938A (fr)
AU (1) AU2019226355A1 (fr)
BR (1) BR112020017626A2 (fr)
CA (1) CA3092163A1 (fr)
EA (1) EA202092045A1 (fr)
IL (1) IL276905A (fr)
MA (1) MA52121A (fr)
MX (1) MX2020008969A (fr)
PH (1) PH12020551331A1 (fr)
SG (1) SG11202008078QA (fr)
WO (1) WO2019166556A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3895726A1 (fr) 2020-04-17 2021-10-20 Pharming Intellectual Property BV Utilisation d'un inhibiteur d'estérase c1 pour traiter une détresse respiratoire aiguë liée à une infection virale
WO2023280981A1 (fr) 2021-07-09 2023-01-12 Pharming Intellectual Property B.V. Utilisation d'un inhibiteur de c1 estérase pour traiter des symptômes liés à une infection virale

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022320A1 (fr) * 1991-06-14 1992-12-23 Genentech, Inc. Variantes de l'inhibiteur c1 et traitement des reactions inflammatoires avec l'inhibiteur c1
GB9618931D0 (en) 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
ATE382635T1 (de) * 2000-01-31 2008-01-15 Pharming Intellectual Pty Bv Humaner c1 inhibitor hergestellt in der milch transgener säugetiere
US7067713B2 (en) * 2000-01-31 2006-06-27 Pharming Intellectual Property B.V. C1 Inhibitor produced in the milk of transgenic non-human mammals
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
ES2830499T3 (es) 2003-05-16 2021-06-03 Pharming Intellectual Property B V Inhibidor de C1 con una semivida corta para un tratamiento transitorio
WO2007073186A2 (fr) 2005-12-21 2007-06-28 Pharming Intellectual Property Bv Utilisation d'un inhibiteur de c1 pour la prevention des lesions d'ischemie-reperfusion
CN105641688B (zh) * 2005-12-21 2020-06-09 法明知识产权股份有限公司 C1抑制剂在预防缺血-再灌注损伤中的应用
EP2912065A4 (fr) * 2012-10-25 2016-10-19 True North Therapeutics Inc Anticorps de la c1s anti-complément et leurs utilisations
US20150330989A1 (en) * 2012-11-15 2015-11-19 The Brigham And Women's Hospital, Inc. Method and system for diagnosing and treating preeclampsia
CN111529708A (zh) 2013-03-15 2020-08-14 夏尔维洛药品公司 用于预防和治疗与c1酯酶抑制剂缺乏相关的病症的c1-inh组合物和方法
WO2016081889A1 (fr) * 2014-11-21 2016-05-26 Kurt Baekgaard Osther Inhibiteur recombinant de la c1-estérase et utilisation de celui-ci
MA45473A (fr) 2016-04-04 2019-02-13 Shire Human Genetic Therapies Inhibiteur de c1 estérase conjugué et ses utilisations
EP3895726A1 (fr) * 2020-04-17 2021-10-20 Pharming Intellectual Property BV Utilisation d'un inhibiteur d'estérase c1 pour traiter une détresse respiratoire aiguë liée à une infection virale

Also Published As

Publication number Publication date
EP3758739A1 (fr) 2021-01-06
JP2021515757A (ja) 2021-06-24
AU2019226355A1 (en) 2020-09-17
MA52121A (fr) 2021-06-02
EP3758739B1 (fr) 2024-05-15
US20200390872A1 (en) 2020-12-17
MX2020008969A (es) 2021-02-16
EA202092045A1 (ru) 2020-11-09
KR20210005549A (ko) 2021-01-14
WO2019166556A1 (fr) 2019-09-06
CA3092163A1 (fr) 2019-09-06
BR112020017626A2 (pt) 2020-12-22
IL276905A (en) 2020-10-29
PH12020551331A1 (en) 2021-09-06
CN111818938A (zh) 2020-10-23

Similar Documents

Publication Publication Date Title
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
GB201804514D0 (en) Treatment of pyroptosis
EP3706736A4 (fr) Agents de dégradation de ash1l et méthodes de traitement au moyen de ceux-ci
IL263368A (en) Prevention and treatment of viral infections
GB201804515D0 (en) Treatment of necroptosis
IL275925A (en) Prevention and treatment of organ damage
ZA202000558B (en) Prevention and/or treatment of neurodegenerative disease
IL276905A (en) Treatment and prevention of preeclampsia
GB201616009D0 (en) Treatment and/or prevention of sepsis
ZA202002669B (en) Prevention and treatment of graft-versus-host-disease with defensins
EP3599983A4 (fr) Endoscopes et méthodes de traitement
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
PT3624812T (pt) Métodos e tratamento de trauma
EP3525771A4 (fr) Prévention et/ou traitement d'une insuffisance rénale aiguë induite par des agents de contraste
IL268860A (en) Granzyme B inhibitor preparations and methods for preventing and/or treating blistered and/or peeling skin
GB201810923D0 (en) Compositions and method of treatment
IL256675A (en) Methods and preparations for the prevention and treatment of pressure sores
GB201815000D0 (en) Treatment of hypothroidism and related conditions
GB201815694D0 (en) Prevention and treatment of cancer
GB201809946D0 (en) Prevention and treatment of cancer
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
SG11202009295YA (en) Treatment and prophylaxis of amyloidosis
IL282686A (en) Treatment and prevention of premature ejaculation